# Drug-drug Interaction (DDI) Study to Assess Effect of Itraconazole and Rifampicin Upon Olorofim

> **NCT04171739** · PHASE1 · COMPLETED · sponsor: **F2G Ltd** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Itraconazole oral solution
- **DRUG:** Rifampicin Oral Capsule
- **DRUG:** Olorofim

## Key facts

- **NCT ID:** NCT04171739
- **Lead sponsor:** F2G Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-18
- **Primary completion:** 2020-02-11
- **Final completion:** 2020-02-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04171739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04171739, "Drug-drug Interaction (DDI) Study to Assess Effect of Itraconazole and Rifampicin Upon Olorofim". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT04171739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*